A VersaTile-driven platform for rapid hit-to-lead development of engineered lysins
Science Advances, vol. 6, pp. eaaz1136
Abstract
in human serum and an ex vivo pig burn wound model. This generic platform could offer new opportunities to populate the preclinical pipeline with engineered lysins for diverse (therapeutic) applications.
Authors 8
-
Affiliation as printed
Department of Biosystems, KU Leuven, Kasteelpark Arenberg 21, 3001 Leuven, Belgium
Department of Biosystems, KU Leuven, Willem de Croylaan 42, 3001 Leuven, Belgium
Department of Biotechnology, Ghent University, Valentin Vaerwyckweg 1, 9000 Gent, Belgium
-
Affiliation as printed
Department of Biotechnology, Ghent University, Valentin Vaerwyckweg 1, 9000 Gent, Belgium
-
Affiliation as printed
Department of Biosystems, KU Leuven, Kasteelpark Arenberg 21, 3001 Leuven, Belgium
Department of Microbial and Molecular Systems, KU Leuven, Kasteelpark Arenberg 23, 3001 Leuven, Belgium
-
Consejo Superior de Investigaciones Científicas · Instituto de Productos Lácteos de Asturias
Affiliation as printed
Dairy Research Institute of Asturias, Spanish National Research Council (IPLA-CSIC), Paseo Río Linares, s/n, 33300 Villaviciosa, Asturias, Spain
-
Affiliation as printed
Department of Microbial and Molecular Systems, KU Leuven, Kasteelpark Arenberg 23, 3001 Leuven, Belgium
Institute of Biology Leiden, Leiden University, Sylviusweg 72, 2333 Leiden, Netherlands
-
Affiliation as printed
Department of Biosystems, KU Leuven, Willem de Croylaan 42, 3001 Leuven, Belgium
-
Affiliation as printed
Department of Biosystems, KU Leuven, Kasteelpark Arenberg 21, 3001 Leuven, Belgium
-
Yves Briers corresponding
Affiliation as printed
Department of Biotechnology, Ghent University, Valentin Vaerwyckweg 1, 9000 Gent, Belgium
Cited by 135 stored of 143
Cited by patents worldwide 8 (Lens.org)
-
CHIMERIC ENDOLYSINSWO2026119912A1 2026-06-11 Pending
-
PEPTIDOGLYCAN HYDROLASES HAVING A CHAP DOMAIN WITH ENGINEERED ACTIVE SITEWO2026057625A1 2026-03-19 Pending
-
PEPTIDOGLYCAN HYDROLASES HAVING MULTIPLE ENZYMATICALLY ACTIVE DOMAINSWO2026057626A1 2026-03-19 Pending
-
ENGINEERED LYSIN POLYPEPTIDE CONSTRUCTS ACTIVE AGAINST GRAM-NEGATIVE BACTERIAWO2024256710A3 2025-01-16 Pending
-
CHIMERIC ENDOLYSINS WITH ACTIVITY AGAINST STREPTOCOCCI AND STAPHYLOCOCCIWO2024200687A1 2024-10-03 Pending
-
PEPTIDOGLYCAN HYDROLASES WITH BACTERICIDAL ACTIVITYWO2024184533A1 2024-09-12 Pending
-
POLYNUCLEOTIDE SHUFFLING METHODEP3555298B1 2024-04-17 Active
-
ANTIBACTERIAL POLYPEPTIDESWO2022189518A1 2022-09-15 Pending